1. Home >
  2. M&A >
  3. Buyout (LBO, MBO, MBI) >
  4. Israel >
  5. Viola Partners Acquires MacroCure

M&A Deal Summary

Viola Partners Acquires MacroCure

On April 27, 2011, private equity firm Viola Partners acquired life science company MacroCure for 13M USD

Acquisition Highlights
  • This is Viola Partners’ 1st transaction in the Life Science sector.
  • This is Viola Partners’ 3rd largest (disclosed) transaction.
  • This is Viola Partners’ 6th transaction in Israel.
Investment Fate
  • MacroCure went public in 2014.
  • MacroCure was sold to a strategic buyer in 2016.

M&A Deal Summary
Date 2011-04-27
Target MacroCure
Sector Life Science
Buyer(s) Viola Partners
Deal Type Buyout (LBO, MBO, MBI)
Deal Value 13M USD

Target

MacroCure

Kiryat Matalon, Petach Tikva, Israel
MacroCure Ltd. is a biotechnology company focused on the development and commercialization of advanced cell therapy products. MacroCure currently manufactures and markets its lead product, CureXcell™, in Israel for difficult-to-heal wound treatment. MacroCure plans to begin a multinational Phase III study under an SPA, in the US, Canada and Israel in the second quarter 2011, for lower extremity ulcers in diabetic patients.

Search 215,029 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Viola Partners

Herzeliya, Israel

Investor Investor Investor

Category Private Equity Firm
Founded 2000
PE ASSETS 290M USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Viola Partners is the private equity investment arm of Viola Group, a diversified investment firm focused on providing credit as well as investing in venture and private equity deals. Viola Partners specializes in technology buyouts and growth capital investments in middle-market companies. The Firm generally looks to invest in Israel and will consider both public and private companies. Viola seeks businesses operating in attractive markets with strong product differentiation and proven business models. The Firm typically invests up to $30 million equity per transaction. Viola Partners was formed in 2000 and is based in Hertzliya, Israel.

DEAL STATS #
Overall 8 of 16
Sector: Life Science M&A 1 of 1
Type: Buyout (LBO, MBO, MBI) M&A Deals 4 of 5
Country: Israel M&A 6 of 10
Year: 2011 M&A 2 of 2
Size (of disclosed) 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-01-31 MobileAccess Networks

Vienna, Virginia, United States

MobileAccess Networks, Inc., is a provider of wireless coverage solutions for all indoor wireless environments. MobileAccess has broad experience deploying its wireless connectivity solutions across vertical markets and around the world, including recent deployments in renowned international facilities. MobileAccess is headquartered in Vienna, Virginia, and has a technology center in the Middle East.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-06-16 MediaMind Technologies

New York, New York, United States

MediaMind Technologies, Inc. was a provider of integrated digital advertising solutions. MediaMind Technologies was formed in 1999 and based in New York City.

Sell $414M
Mergr

Solution for

Product

Company

Legal